Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Clinical trial NCT00554827 · COMPLETED
Trial details
- NCT number
- NCT00554827
- Sponsor
- Acrotech Biopharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2012-01-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.